Literature DB >> 18424695

Cutting edge: Dendritic cells prime a high avidity CTL response independent of the level of presented antigen.

Charles J Kroger1, Samuel Amoah, Martha A Alexander-Miller.   

Abstract

CTL that possess a high functional avidity are known to be optimal for the clearance of pathogens in vivo. We have shown that the amount of peptide encountered by a CD8+ CTL determines its functional avidity. Notably, in these studies nonprofessional APC were used. However, it is mature dendritic cells (DC) that are predominantly responsible for the activation of naive T cells in vivo. Whether DC also direct dose dependent-differences in avidity is unknown. In this work we examined the ability of mature DC presenting a high vs low level of peptide to generate CTL of distinct avidities. In contrast to what was observed with nonprofessional APC, CTL generated by stimulation with mature DC were of high avidity regardless of the amount of peptide presented. This DC property may promote generation of highly effective CTL that retain plasticity, which would allow the tuning of avidity in the periphery to promote optimal pathogen recognition and clearance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424695      PMCID: PMC3702053          DOI: 10.4049/jimmunol.180.9.5784

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism.

Authors:  Shuwen Xu; Gary K Koski; Mark Faries; Isabelle Bedrosian; Rosemarie Mick; Markus Maeurer; Martin A Cheever; Peter A Cohen; Brian J Czerniecki
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

2.  IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells.

Authors:  SangKon Oh; Liyanage P Perera; Donald S Burke; Thomas A Waldmann; Jay A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

3.  Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

Authors:  M A Alexander-Miller; G R Leggatt; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

Review 4.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

5.  Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL.

Authors:  M A Alexander-Miller; G R Leggatt; A Sarin; J A Berzofsky
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

6.  Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody.

Authors:  A Porgador; J W Yewdell; Y Deng; J R Bennink; R N Germain
Journal:  Immunity       Date:  1997-06       Impact factor: 31.745

7.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.

Authors:  H Pircher; K Bürki; R Lang; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

8.  Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides.

Authors:  A Gallimore; T Dumrese; H Hengartner; R M Zinkernagel; H G Rammensee
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

9.  CD8 beta increases CD8 coreceptor function and participation in TCR-ligand binding.

Authors:  V Renard; P Romero; E Vivier; B Malissen; I F Luescher
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

10.  Antigen-dependent and -independent Ca2+ responses triggered in T cells by dendritic cells compared with B cells.

Authors:  J Delon; N Bercovici; G Raposo; R Liblau; A Trautmann
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more
  10 in total

1.  Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppression.

Authors:  Olusimidele T Akinsiku; Anju Bansal; Steffanie Sabbaj; Sonya L Heath; Paul A Goepfert
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

2.  In vivo modulation of avidity in highly sensitive CD8(+) effector T cells following viral infection.

Authors:  Beth C Holbrook; Rama D Yammani; Lance K Blevins; Martha A Alexander-Miller
Journal:  Viral Immunol       Date:  2013-08-24       Impact factor: 2.257

3.  Increased sensitivity to antigen in high avidity CD8(+) T cells results from augmented membrane proximal T-cell receptor signal transduction.

Authors:  Sharad K Sharma; Martha A Alexander-Miller
Journal:  Immunology       Date:  2011-04-19       Impact factor: 7.397

4.  Changes in autoreactive T cell avidity during type 1 diabetes development.

Authors:  Nathan E Standifer; Emily A Burwell; Vivian H Gersuk; Carla J Greenbaum; Gerald T Nepom
Journal:  Clin Immunol       Date:  2009-05-23       Impact factor: 3.969

Review 5.  Constant regulation for stable CD8 T-cell functional avidity and its possible implications for cancer immunotherapy.

Authors:  Connie B Gilfillan; Michael Hebeisen; Nathalie Rufer; Daniel E Speiser
Journal:  Eur J Immunol       Date:  2021-03-30       Impact factor: 5.532

6.  Dendritic cells reveal a broad range of MHC class I epitopes for HIV-1 in persons with suppressed viral load on antiretroviral therapy.

Authors:  Xiao-Li Huang; Zheng Fan; LuAnn Borowski; Robbie B Mailliard; Morgane Rolland; James I Mullins; Richard D Day; Charles R Rinaldo
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

7.  High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection.

Authors:  Niamh M Keane; Steven G Roberts; Coral-Ann M Almeida; Tanya Krishnan; Abha Chopra; Emma Demaine; Rebecca Laird; Monika Tschochner; Jonathan M Carlson; Simon Mallal; David Heckerman; Ian James; Mina John
Journal:  Immunol Cell Biol       Date:  2011-05-17       Impact factor: 5.126

8.  Reduced interleukin-4 receptor α expression on CD8+ T cells correlates with higher quality anti-viral immunity.

Authors:  Danushka K Wijesundara; David C Tscharke; Ronald J Jackson; Charani Ranasinghe
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

Review 9.  Peptide Dose and/or Structure in Vaccines as a Determinant of T Cell Responses.

Authors:  Graham R Leggatt
Journal:  Vaccines (Basel)       Date:  2014-07-02

10.  Mature Dendritic Cells May Promote High-Avidity Tuning of Vaccine T Cell Responses.

Authors:  Adarsh Kumbhari; Colt A Egelston; Peter P Lee; Peter S Kim
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.